Post published:January 1, 2023 Post category:Our History Post comments:0 Comments Reading time:0 mins read 23 Views Please Share This Share this content Opens in a new window X Opens in a new window Facebook Opens in a new window WhatsApp Opens in a new window LinkedIn Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment. Read more articles Previous PostIncrease the R&D efforts of ELISA technology R&D platform, FCM technology R&D platform, and IVD detection reagents, and continuously launch new products to serve clinical and scientific research. Next PostTumor necrosis factor (TNF): TNF-α & TNF-β You Might Also Like Increase the R&D efforts of ELISA technology R&D platform, FCM technology R&D platform, and IVD detection reagents, and continuously launch new products to serve clinical and scientific research. January 1, 2022 Implemented the core strategy of independent brand and passed the ISO9001 international quality system certification. January 1, 2018 Build a GMP production plant, and 3 Class III products are under registration. January 1, 2021 Established R&D and production departments, and developed independent products represented by ELISA January 1, 2010 Entered the IVD field, with a total of 115 Class I registration certificates January 3, 2020 Company Formation April 26, 2002 National high-tech enterprise, Hangzhou Enterprise High-tech R&D Center January 1, 2019
Increase the R&D efforts of ELISA technology R&D platform, FCM technology R&D platform, and IVD detection reagents, and continuously launch new products to serve clinical and scientific research. January 1, 2022
Implemented the core strategy of independent brand and passed the ISO9001 international quality system certification. January 1, 2018
Established R&D and production departments, and developed independent products represented by ELISA January 1, 2010
